A human trial for two drugs which are YAMANIPANCHAKA VATI and DEVADARVYADI VATI for the treatment of Grahni Roga w.s.r IBS in children

A RANDOMISED CONTROL TRIAL ON YAMANIPANCHAKA VATI AND DEVADARVYADI VATI IN THE MANAGEMENT OF GRAHNI ROGA W.S.R. IBS IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101461

Enrollment

150

Registered

2026-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject of age group 5 year to 16 year. 2. Subject suffering from symptoms of Grahani (mild to moderate IBS)

Exclusion criteria

Exclusion criteria: 1. Subject Below age 5 year and Above 16 year of age. 2. Subjects with severe diarrhea and dehydration. 3. Subject with complications; Chronic disease. 4. Subject with PEM/ SAM/MAM. 5. Subject has history of any disease- DM / CHD etc. 6. Mentally retarded subjects

Design outcomes

Primary

Measure	Time frame
From this clinical study, it is expected to have a better drug option out of these two that will be available for Grahni Roga in children and will be most effective and have no side-effects.Timepoint: The follow ups or outcomes are assessed at 0th day(baseline), 14th day, 28th day, 42nd day.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactProf Dr Hemraj

Desh Bhagat Ayurvedic College

hemraj22@gmail.com9418004077

Outcome results